BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3902988)

  • 1. A specific inhibitor of keratinolytic proteinase from Candida albicans could inhibit the cell growth of C. albicans.
    Tsuobi R; Kurita Y; Negi M; Ogawa H
    J Invest Dermatol; 1985 Nov; 85(5):438-40. PubMed ID: 3902988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinolytic proteinase produced by Candida albicans.
    Hattori M; Yoshiura K; Negi M; Ogawa H
    Sabouraudia; 1984; 22(3):175-83. PubMed ID: 6205458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Candida albicans producing proteinase (CAPP) and its environmental pH--comparison with a case of trichophyton mentagrophytes.
    Ko IJ; Kim CW; Houh W; Tsuboi R; Matsuda K; Ogawa H
    J Korean Med Sci; 1987 Jun; 2(2):97-101. PubMed ID: 3078111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of proteinase from Candida albicans: substrate specificity.
    Negi M; Tsuboi R; Matsui T; Ogawa H
    J Invest Dermatol; 1984 Jul; 83(1):32-6. PubMed ID: 6203988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of miconazole of the growth of Candida albicans.
    Van Den Bossche H; Willemsens G; Van Cutsem JM
    Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of culture medium pH and proteinase inhibitors on extracellular proteinase activity and cell growth of Sporothrix schenckii.
    Tsuboi R; Sanada T; Ogawa H
    J Clin Microbiol; 1988 Jul; 26(7):1431-3. PubMed ID: 3045155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetracycline-inducible expression of individual secreted aspartic proteases in Candida albicans allows isoenzyme-specific inhibitor screening.
    Staib P; Lermann U; Blass-Warmuth J; Degel B; Würzner R; Monod M; Schirmeister T; Morschhäuser J
    Antimicrob Agents Chemother; 2008 Jan; 52(1):146-56. PubMed ID: 17954688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antifungal activity of medicinal plant extracts against oral Candida albicans and proteinases.
    Höfling JF; Mardegan RC; Anibal PC; Furletti VF; Foglio MA
    Mycopathologia; 2011 Aug; 172(2):117-24. PubMed ID: 21409409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between culture medium pH, extracellular proteinase activity, and cell growth of Candida albicans in insoluble stratum corneum-supplemented media.
    Tsuboi R; Matsuda K; Ko IJ; Ogawa H
    Arch Dermatol Res; 1989; 281(5):342-5. PubMed ID: 2679408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-associated collagenolytic activity by Candida albicans.
    Nishimura M; Nikawa H; Yamashiro H; Nishimura H; Hamada T; Embery G
    Mycopathologia; 2002; 153(3):125-8. PubMed ID: 11998872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum.
    Niwano Y; Matsui M; Tabuchi T; Kanai K; Hamaguchi H; Miyazaki T; Uchida K; Yamaguchi H
    Arzneimittelforschung; 1997 Sep; 47(9):1056-60. PubMed ID: 9342423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of human subendothelial extracellular matrix by proteinase-secreting Candida albicans.
    Morschhäuser J; Virkola R; Korhonen TK; Hacker J
    FEMS Microbiol Lett; 1997 Aug; 153(2):349-55. PubMed ID: 9271862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and properties of three intracellular proteinases from Candida albicans.
    Portillo F; Gancedo C
    Biochim Biophys Acta; 1986 Apr; 881(2):229-35. PubMed ID: 3513844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ritonavir and saquinavir on Candida albicans growth rate and in vitro activity of aspartyl proteinases.
    Blanco MT; Hurtado C; Pérez-Giraldo C; Morán FJ; González-Velasco C; Gómez-García AC
    Med Mycol; 2003 Apr; 41(2):167-70. PubMed ID: 12964850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal effect of zeolite-incorporated tissue conditioner against Candida albicans growth and/or acid production.
    Nikawa H; Yamamoto T; Hamada T; Rahardjo MB; Murata H; Nakanoda S
    J Oral Rehabil; 1997 May; 24(5):350-7. PubMed ID: 9183028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans.
    Schaller M; Krnjaic N; Niewerth M; Hamm G; Hube B; Korting HC
    J Med Microbiol; 2003 Mar; 52(Pt 3):247-249. PubMed ID: 12621090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents?
    Bona E; Cantamessa S; Pavan M; Novello G; Massa N; Rocchetti A; Berta G; Gamalero E
    J Appl Microbiol; 2016 Dec; 121(6):1530-1545. PubMed ID: 27568869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and properties of a pepstatin-insensitive carboxyl proteinase from a gram-negative bacterium.
    Oda K; Sugitani M; Fukuhara K; Murao S
    Biochim Biophys Acta; 1987 Mar; 923(3):463-9. PubMed ID: 3548827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of coronarin D against Candida albicans.
    Kaomongkolgit R; Jamdee K; Wongnoi S; Chimnoi N; Techasakul S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):61-6. PubMed ID: 22727093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida guilliermondii isolated from HIV-infected human secretes a 50 kDa serine proteinase that cleaves a broad spectrum of proteinaceous substrates.
    Dos Santos AL; Soares RM
    FEMS Immunol Med Microbiol; 2005 Jan; 43(1):13-20. PubMed ID: 15607631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.